Sarepta Therapeutics, Inc. — Director's Dealing 2018

Mar 16, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Sarepta Therapeutics, Inc. (SRPT)
CIK: 0000873303
Period of Report: 2018-03-15

Reporting Person: Mahatme Sandesh (EVP, CFO & CBO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-03-15	Common Stock	M	2500	$23.85	Acquired	43395	Direct
2018-03-15	Common Stock	F	734	$81.22	Disposed	42661	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-03-15	Stock option (right to buy)	$23.85	M	2500	Disposed	2022-11-05	Common Stock (2500)	Direct

Footnotes

F1: The Reporting Person delivered already-owned shares of Common Stock in payment of the option exercise price. Such an "option swap" enables the exercise and holding of shares of Common Stock by the Reporting Person.